Status:
COMPLETED
Effect of Daily Low Dose Aspirin on Exhaled Inflammatory Mediators in Normal Subjects
Lead Sponsor:
Brigham and Women's Hospital
Conditions:
Healthy
Eligibility:
All Genders
18-95 years
Phase:
NA
Brief Summary
Hypothesis: Low dose aspirin does not change exhaled inflammatory breath mediators in normal subjects.
Detailed Description
Aim: 1. To study the effect of low dose aspirin on exhaled breath inflammatory mediators 2. To compare the change to that seen in diseased states such as asthma and Lymphangioleiomyomatosis (LAM) We...
Eligibility Criteria
Inclusion
- healthy adults
Exclusion
- any underlying major medical conditions such as heart disease, hypertension, stroke, diabetes, bleeding disorders
Key Trial Info
Start Date :
May 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2009
Estimated Enrollment :
4 Patients enrolled
Trial Details
Trial ID
NCT00898222
Start Date
May 1 2009
End Date
August 1 2009
Last Update
September 25 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Asthma Research Center, Brigham and Women's Hospital
Boston, Massachusetts, United States, 02115